Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| IL2RG | P31785 | Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132) | Cancer-related genesCD markersDisease related genes | 1 | SCID | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 8 | 0.63 | ||
| ANK3 | Q12955 | Ankyrin-3 (ANK-3) (Ankyrin-G) | Cancer-related genesDisease related genesHuman disease related genes | Autism spectrum disorderIntellectual disability | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 7 | 0.63 | |||
| APOBR | Q0VD83 | Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor) (Apolipoprotein B48 receptor) (apoB-48R) | Predicted intracellular proteins | Atherosclerosis | Fusion and delivery mediation | 7 | 0.63 | |||
| CADH6 | P55285 | Cadherin-6 (Kidney cadherin) (K-cadherin) | Plasma proteinsPredicted membrane proteins | 1 | Ovarian cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 7 | 0.63 | ||
| CD19 | P15391 | B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19) | CD markersDisease related genesFDA approved drug targets | 1 | Acute myeloid leukaemiaB-cell lymphomaDiabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 7 | 0.63 | ||
| DSC2 | Q02487 | Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III) | Disease related genesHuman disease related genesPlasma proteins | 1 | Cardiomyopathy | Adhesion and uptake mediationFusion and delivery mediation | 7 | 0.63 | ||
| EI2BB | P49770 | Translation initiation factor eIF2B subunit beta (S20I15) (S20III15) (eIF2B GDP-GTP exchange factor subunit beta) | Disease related genesEssential proteinsHuman disease related genes | Leukodystrophy | Immune mediationMetabolism mediation | 7 | 0.63 | |||
| FAD1 | Q8NFF5 | Bifunctional FAD diphosphatase/FAD synthase [Includes: FAD diphosphatase (EC 3.6.1.18) (EC 3.6.1.22) (FAD pyrophosphatase) (FADPPase) (FADHy) (NADH diphosphatase); FAD synthase (FADSy) (EC 2.7.7.2) (FMN adenylyltransferase) (FMNAT) (Flavin adenine dinucleotide synthase)] | Disease related genesEnzymesHuman disease related genes | Primary mitochondrial disease | Metabolism mediation | 7 | 0.63 | |||
| AA1R | P30542 | Adenosine receptor A1 | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Acute diabetic complicationAllergic/hypersensitivity disorderCardiac arrhythmia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||
| CADM3 | Q8N126 | Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (SynCAM3) (TSLC1-like protein 1) (TSLL1) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Charcot-Marie-Tooth disease | Adhesion and uptake mediationReceptor-signaling mediation | 6 | 0.63 |